Результаты применения гемопоэтических факторов роста после высокодозной химиотерапии с трансплантацией стволовых гемопоэтических клеток

Е. А. Кузьмич, В А Змачинский · Проблемы здоровья и экологии · 2011

The article presents early and long-term results of the combined application of haemopoetic growth factors, i.e. erythropoietin and granulocyte colony-stimulating factor after high-dose chemotherapy with haemopoetic stem cell transplantation in patients with hematologic and oncohematologic disorders. It has been established that the combined therapy with haemopoetic growth factors after the allogeneic transplantation of haemopoetic stem cell leads to better donor marrow engraftment. This reduces the average patients` stay at hospital in the posttransplantation period and increases the indicators of 5-year-old non-relapsing survival rate of patients with Hodzhkin`s lymphoma treated with a combination of erythropoietin and granulocyte colony-stimulating factor.

Cited by 0 works.

Authors